To have a successful integration of data from across clinical systems, a strong understanding of the data is a critical.
Oncology drug developers must start asking questions in preparation of FDA’s dose optimization initiative.
Industry must work closely with patients to advance the use of decentralized technology.
Fostering common eConsent terminologies enriches communication and understanding across all stakeholders.
Laboratory services organization focuses on easing patient and site burden with improved collection device.
Sponsors need to develop a strategy on how to evaluate the impact of the pandemic on the re-start of halted trials.
COVID-19 speeds up clinical research and creates new advancements within industry.
Survey taken by CROs and pharma/biotech companies seeks answers in maximizing partnership.
A discussion of the regulatory history behind audit trails and its interpretation as it relates to clinical research data originating or residing in EDC or eCOA systems.
How pharmaceutical start-ups can mitigate risk and avoid costly hiring mistakes.
Master protocols helped accelerate research during the pandemic in the EU. How can US companies learn from this and start preparing master protocols now?
How can managers ensure their clinical trial participants represent future patients?
Looking beyond regulatory compliance.
2020 Tufts CSDD – IBM Watson Health benchmarking study highlights need for new functionality from EDC solutions and providers.
Successful collaborations between Pharma/Biotech/Device industries and CROs will play a key role in an effective fight against the global COVID-19 pandemic.
In light of Facebook ban on ads targeting patients, industry has chance to reinvent digital advertising for trials.
Trials that address multiple questions simultaneously using a master protocol can be operationally complicated. These complexities can be managed, even in studies used to support a marketing application.
Wearables have great potential to continue advancing research in Rett syndrome as well as other rare disease areas.
Shiri Diskin, PhD, Head of Medical Writing at Bioforum, sits down with Daphna Laifenfeld, PhD, Chief Scientific Officer at Ibex Medical Analytics to discuss the challenges associated with developing a CER and how to effectively navigate them while creating opportunities that increase efficiencies.
Centralized medical imaging providers must challenge their current processes to improve patient diversity.
The potential of PBPK modeling in answering key questions around these drugs.
Webinar Date/Time: Thu, Mar 2, 2023 1:00 PM EST
Employing a Multi-faceted Approach to Cultivate Inclusivity and Close Disparity.
A use case by Memorial Sloan Kettering Cancer Center explores the potential of EHR-to-EDC.
Advances in technology open door for improved EHR to EDC transfer process.
Regulatory compliance, collaboration, and effective use of technology among ways CROs can overcome challenges.
Tufts CSDD survey finds fostering healthy relationships with site staff is key to a positive outlook.